Chronic Pancreatitis Pain Market Size, Share, Trends & Research 2030

According to the report, global demand for Chronic Pancreatitis Pain market was valued at approximately USD 7.8 billion in 2019, and is expected to generate revenue of around USD 11.1 billion by end of 2026, growing at a CAGR of around 5.2 % between 2020 and 2026.

Chronic pancreatitis is a long term inflammation of pancreas which leads to permanent damage and digestion capability of pancreas. Most common symptoms include severe abdominal pain, diabetes, weight loss, producing greasy and foul-smelling stools etc. Common cause associated with chronic pancreatitis is heavy alcohol consumption. Other causes include hereditary disorders of pancreas, gall stones, cystic fibrosis, certain medication etc. CT scan, magnetic resonance cholangiopancreatography, ultrasound sonography are diagnostic tests used for chronic pancreatitis patients.

Request Free Sample

Chronic pancreatitis pain market is mostly driven by increasing number of chronic pancreatitis patients across globe. Furthermore, increasing alcohol consumption, torpid lifestyles are contribute towards the growth of chronic pancreatitis pain market. Ongoing research and development in the healthcare literacy rate is expected to open growth avenues for the market over the years.

The report covers forecast and analysis of the chronic pancreatitis pain market on a global and regional level. The study provides historic data of 2015 along with a forecast from 2016 to 2021 based on revenue (USD Million). To understand the competitive landscape in the market, an analysis of Porter’s Five Forces model for the chronic pancreatitis pain drug market has also been included in the study. The report also analyzes several driving and restraining factors and their impact on the market during the forecast period. The study encompasses a market attractiveness analysis, wherein application segments are benchmarked based on their market size, growth rate and general attractiveness.

The report provides detailed segmentation of the chronic pancreatitis pain drug market based on therapy, and regional segment.

Geographically, the market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Demand has been analyzed and forecast based on the current trends of the market. North America was the leading segment of chronic pancreatitis pain market followed by Europe in 2015 due to continuous increase in alcohol consumption. The chronic pancreatitis pain market is expected to witness the highest growth in the Asia-Pacific region mainly in China and India in the coming years due to the rising population, awareness as well as government initiative in these countries.

Key players in chronic pancreatitis pain market include Abbott, Aptalis Pharma, Inc., McNeil Consumer Healthcare and Sun Biopharma.

Global Chronic Pancreatitis Pain Market: Report Scope:

This report segments the chronic pancreatitis pain market are:-

 Chronic Pancreatitis Pain Market: Type Analysis

• Medicinal therapy
• Surgical therapy
• Endoscopic therapy

 Chronic Pancreatitis Pain Market: Regional Analysis

• North America
• Europe
• Asia pacific
• Latin America
• Middle east & Africa